{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:18:33Z","timestamp":1781795913201,"version":"3.54.5"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Normocalcemic hyperparathyroidism (NHPT) is variably defined, and information regarding complications and natural history are scarce. We aimed to describe the phenotype of NHPT in relation to hypercalcemic hyperparathyroidism (PHPT) and controls, to determine risk of progression, and to develop a predictive model for progression to PHPT. This is a retrospective chart review of 232 patients at a tertiary medical center, comparing 75 controls, 73 patients with NHPT, and 84 with PHPT. NHPT was intermediate in biochemical profile between controls and PHPT with respect to cCa, iPTH, intraindividual coefficient of variant of cCa, phosphorus, and 25(OH)D. NHPT patients had an increased adjusted risk of urolithiasis (OR 5.34, 95%CI, 2.41-12.71, P\u2009&amp;lt;\u2009.001) and fragility fractures (OR 4.53, 95%CI, 1.63-14.84, P\u2009=\u2009.006) versus controls, after adjustment for age, sex, and BMI. Fewer NHPT compared with PHPTH patients achieved cure with parathyroidectomy (P\u2009=\u2009.001). NHPT more often had nonlocalizing imaging or polyglandular disease (P\u2009=\u2009.005). Parathyroidectomy improved biochemical but not BMD parameters in NHPT. Over a median follow-up of 4.23 (IQR 1.76-5.31) years, NHPT patients managed expectantly experienced no change in iPTH, and progression to PHPT occurred in 9%. An XGBoost model combining 6 factors for progression (mean index 2 iPTH, mean index 2 cCa, 24-h urinary calcium, age, 25(OH)D, and presence of urolithiasis) had an area under the curve 1.00 (95%CI, 1.00-1.00, P\u2009&amp;lt;\u2009.001) for predicting combined progression. NHPT is a mild variant of PHPT at intermediate risk of urolithiasis and fragility fractures. Cure was less often achieved with parathyroidectomy, which did not improve BMD parameters. Progression was infrequent with conservative management. Because only a minority progressed to PHPT, in addition to lower surgical success rates, we suggest conservative management for the majority of NHPT unless risk factors for progression are identified.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziae074","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T21:02:52Z","timestamp":1717016572000},"source":"Crossref","is-referenced-by-count":3,"title":["Natural history and complications of normocalcemic hyperparathyroidism: a retrospective cohort study"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-5477","authenticated-orcid":false,"given":"Caroline Wei Shan","family":"Hoong","sequence":"first","affiliation":[{"name":"Division of Endocrinology , Diabetes, Metabolism and Nutrition, Department of Medicine, , Rochester, MN 55905 , United States"},{"name":"Mayo Clinic Rochester , Diabetes, Metabolism and Nutrition, Department of Medicine, , Rochester, MN 55905 , United States"},{"name":"Department of Endocrinology, Woodlands Health, National Healthcare Group , 737628 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Broski","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic Rochester , MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad G","family":"Sfeir","sequence":"additional","affiliation":[{"name":"Division of Endocrinology , Diabetes, Metabolism and Nutrition, Department of Medicine, , Rochester, MN 55905 , United States"},{"name":"Mayo Clinic Rochester , Diabetes, Metabolism and Nutrition, Department of Medicine, , Rochester, MN 55905 , United States"},{"name":"Robert and Arlene Kogod Center on Aging, Mayo Clinic Rochester , MN 55905 , United States"},{"name":"Division of Geriatric Medicine and Gerontology , Department of Medicine, , MN 55905 , United States"},{"name":"Mayo Clinic Rochester , Department of Medicine, , MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart Lyman","family":"Clarke","sequence":"additional","affiliation":[{"name":"Division of Endocrinology , Diabetes, Metabolism and Nutrition, Department of Medicine, , Rochester, MN 55905 , United States"},{"name":"Mayo Clinic Rochester , Diabetes, Metabolism and Nutrition, Department of Medicine, , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"issue":"4","key":"2024091717260801400_ref1","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic hyperparathyroidism: study of its prevalence and natural history","volume":"105","author":"Schini","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024091717260801400_ref2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","article-title":"Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?","volume":"55","author":"Marques","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"8","key":"2024091717260801400_ref3","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024091717260801400_ref4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"8","key":"2024091717260801400_ref5","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10391","article-title":"Normocalcemic hyperparathyroidism: a heterogeneous disorder often misdiagnosed?","volume":"4","author":"Zavatta","year":"2020","journal-title":"JBMR Plus"},{"issue":"11","key":"2024091717260801400_ref6","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024091717260801400_ref7","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","article-title":"Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024091717260801400_ref8","volume-title":"Dietary Reference Intakes for Calcium and Vitamin D [Internet]","author":"Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium","year":"2011"},{"issue":"7","key":"2024091717260801400_ref9","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024091717260801400_ref10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s001980050030","article-title":"Prevalence of vitamin D insufficiency in an adult normal population","volume":"7","author":"Chapuy","year":"1997","journal-title":"Osteoporos Int"},{"issue":"11","key":"2024091717260801400_ref11","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2012-2276","article-title":"Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels","volume":"97","author":"Valcour","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024091717260801400_ref12","volume-title":"Urine Calcium: Reference Range, Interpretation, Collection and Panels"},{"issue":"3","key":"2024091717260801400_ref13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00198-020-05615-6","article-title":"Reference range for 24-hour urine calcium, calcium\/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women","volume":"32","author":"Smith","year":"2021","journal-title":"Osteoporos Int"},{"issue":"9","key":"2024091717260801400_ref14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1308\/rcsann.2021.0333","article-title":"Excluding familial hypocalciuric hypercalcaemia before surgery for primary hyperparathyroidism - a practical evaluation of urinary calcium using a retrospective cohort design","volume":"104","author":"McAllister","year":"2022","journal-title":"Ann R Coll Surg Engl"},{"issue":"5893","key":"2024091717260801400_ref15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","article-title":"Interpretation of serum calcium in patients with abnormal serum proteins","volume":"4","author":"Payne","year":"1973","journal-title":"Br Med J"},{"issue":"6","key":"2024091717260801400_ref16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s001980170087","article-title":"Standardization of bone mineral density at femoral neck, trochanter and Ward\u2019s triangle","volume":"12","author":"Lu","year":"2001","journal-title":"Osteoporos Int"},{"issue":"10","key":"2024091717260801400_ref17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","article-title":"Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results","volume":"9","author":"Genant","year":"1994","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024091717260801400_ref18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1359\/jbmr.2002.17.4.734","article-title":"Universal standardization of forearm bone densitometry","volume":"17","author":"Shepherd","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024091717260801400_ref19","first-page":"785","volume-title":"Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining [Internet]","author":"Chen","year":"2016"},{"issue":"6","key":"2024091717260801400_ref20","first-page":"1019","article-title":"Clinical usefulness of an intraoperative \u201cquick parathyroid hormone\u201d assay","volume":"114","author":"Irvin","year":"1993","journal-title":"Surgery"},{"issue":"4","key":"2024091717260801400_ref21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/a-0859-1020","article-title":"Normocalcemic primary hyperparathyroidism in adults without a history of nephrolithiasis or fractures: a prospective study","volume":"51","author":"Ros\u00e1rio","year":"2019","journal-title":"Horm Metab Res"},{"issue":"3","key":"2024091717260801400_ref22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4158\/EP09346.OR","article-title":"Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases","volume":"17","author":"Norman","year":"2011","journal-title":"Endocr Pract"},{"issue":"3","key":"2024091717260801400_ref23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2215\/CJN.05181008","article-title":"Asymptomatic nephrolithiasis detected by ultrasound","volume":"4","author":"Bansal","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2024091717260801400_ref24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.juro.2009.11.047","article-title":"Prevalence of urolithiasis in asymptomatic adults: objective determination using low dose noncontrast computerized tomography","volume":"183","author":"Boyce","year":"2010","journal-title":"J Urol"},{"issue":"1","key":"2024091717260801400_ref25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00240-020-01210-w","article-title":"Trends in the prevalence of kidney stones in the United States from 2007 to 2016","volume":"49","author":"Chewcharat","year":"2021","journal-title":"Urolithiasis"},{"key":"2024091717260801400_ref26","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/128352","article-title":"Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone?","volume":"2012","author":"Amaral","year":"2012","journal-title":"J Osteoporos"},{"issue":"5","key":"2024091717260801400_ref27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00268-001-0262-6","article-title":"Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone sisease before and after parathyroidectomy","volume":"26","author":"Fr\u00f8kjaer","year":"2002","journal-title":"World J Surg"},{"issue":"1","key":"2024091717260801400_ref28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1479-5876-9-201","article-title":"Calcium-sensing receptor and calcium kidney stones","volume":"9","author":"Vezzoli","year":"2011","journal-title":"J Transl Med"},{"issue":"3","key":"2024091717260801400_ref29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00423-018-1659-0","article-title":"Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?","volume":"403","author":"Traini","year":"2018","journal-title":"Langenbeck's Arch Surg"},{"issue":"9","key":"2024091717260801400_ref30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.eprac.2021.06.004","article-title":"Association of parathyroidectomy with 5-year clinically significant kidney stone events in patients with primary hyperparathyroidism","volume":"27","author":"Seib","year":"2021","journal-title":"Endocr Pract"},{"issue":"7","key":"2024091717260801400_ref31","doi-asserted-by":"crossref","first-page":"e2801","DOI":"10.1210\/clinem\/dgac193","article-title":"Kidney stone events following parathyroidectomy vs nonoperative management for primary hyperparathyroidism","volume":"107","author":"Seib","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024091717260801400_ref32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.surg.2021.03.077","article-title":"Parathyroidectomy for nephrolithiasis in primary hyperparathyroidism: beneficial but not a panacea","volume":"171","author":"Huang","year":"2022","journal-title":"Surgery"},{"issue":"1","key":"2024091717260801400_ref33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4081\/aiua.2015.1.66","article-title":"Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study","volume":"87","author":"Brardi","year":"2015","journal-title":"Arch Ital Urol Androl"},{"issue":"4","key":"2024091717260801400_ref34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00268-012-1438-y","article-title":"Surgical management of normocalcemic primary hyperparathyroidism","volume":"36","author":"Wade","year":"2012","journal-title":"World J Surg"},{"issue":"8","key":"2024091717260801400_ref35","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024091717260801400_ref36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","article-title":"Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women","volume":"42","author":"Garc\u00eda-Mart\u00edn","year":"2012","journal-title":"Endocrine"},{"issue":"2","key":"2024091717260801400_ref37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cen.12819","article-title":"Normocalcaemic, vitamin D-sufficient hyperparathyroidism \u2013 high prevalence and low morbidity in the general population: a long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden","volume":"83","author":"Kontogeorgos","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"7","key":"2024091717260801400_ref38","doi-asserted-by":"crossref","first-page":"e2609","DOI":"10.1210\/clinem\/dgaa174","article-title":"Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism","volume":"105","author":"Palermo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024091717260801400_ref39","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024091717260801400_ref40","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jbmr.3461","article-title":"Prevalence and risk of vertebral fractures in primary hyperparathyroidism: a nested case-control study","volume":"33","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024091717260801400_ref41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/jcm11020330","article-title":"Bone mineral density compared to trabecular bone score in primary hyperparathyroidism","volume":"11","author":"Jones","year":"2022","journal-title":"J Clin Med"},{"issue":"10","key":"2024091717260801400_ref42","doi-asserted-by":"crossref","first-page":"030006052096469","DOI":"10.1177\/0300060520964698","article-title":"Changes in bone mineral density after parathyroidectomy in patients with moderate to severe primary hyperparathyroidism","volume":"48","author":"Lu","year":"2020","journal-title":"J Int Med Res"},{"issue":"9","key":"2024091717260801400_ref43","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024091717260801400_ref44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00268-022-06756-x","article-title":"Parathyroidectomy for normocalcemic primary hyperparathyroidism is associated with improved bone mineral density regardless of postoperative parathyroid hormone levels","volume":"47","author":"Lui","year":"2023","journal-title":"World J Surg"},{"issue":"1","key":"2024091717260801400_ref45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.surg.2019.06.043","article-title":"Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis","volume":"167","author":"Pandian","year":"2020","journal-title":"Surgery"},{"issue":"2","key":"2024091717260801400_ref46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","article-title":"Normocalcemic primary hyperparathyroidism","volume":"54","author":"Bilezikian","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"2024091717260801400_ref47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4158\/EP15704.OR","article-title":"Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat?","volume":"22","author":"\u0160iprov\u00e1","year":"2016","journal-title":"Endocr Pract"},{"issue":"5","key":"2024091717260801400_ref48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin Endocrinol"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziae074\/58029407\/ziae074.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/8\/7\/ziae074\/59144672\/ziae074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/8\/7\/ziae074\/59144672\/ziae074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:26:28Z","timestamp":1726593988000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziae074\/7685659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziae074","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,31]]},"article-number":"ziae074"}}